Sam Ruttonsha has been appointed president and CEO of Synapse Technologies Inc to spearhead the Vancouver-based company’s plans to secure new research collaborations and a major partnership to bring its technology to market. Ruttonsha has a strong background in the financing of start-ups, turnarounds and technology firms and has an extensive track record of mergers and acquisitions in biotechnology and other fields. Backed by a strong slate of venture capital investment, Synapse has developed technology to deliver drugs across the blood brain barrier and has developed a screening test for Alzheimer’s disease....